Letter to the Editor: Is Aristolochic Acid the Major Cause of Liver Cancer in China and Asia?
Jia‐bo Wang, Zhao‐fang Bai, Xiao‐he Xiao – 14 October 2019
Differential Impact of Age Among Liver Transplant Candidates With and Without Hepatocellular Carcinoma
Giuseppe Cullaro, Jessica B. Rubin, Neil Mehta, Jennifer C. Lai – 14 October 2019 – Hepatocellular carcinoma (HCC) is the fastest‐rising cause of cancer‐related mortality in the United States and is a leading indication for liver transplantation (LT). Changes have been noted in the age of the population with chronic liver disease, but how this change affects patients with HCC is unknown. This study aims to characterize trends and transplant‐associated outcomes among patients ≥65 years old listed for LT with HCC.
Yes‐Associated Protein in Kupffer Cells Enhances the Production of Proinflammatory Cytokines and Promotes the Development of Nonalcoholic Steatohepatitis
Kyoungsub Song, Hyunjoo Kwon, Chang Han, Weina Chen, Jinqiang Zhang, Wenbo Ma, Srikanta Dash, Chandrashekhar R. Gandhi, Tong Wu – 14 October 2019
Outcome of Liver Transplant Patients With Preformed Donor‐Specific Anti–Human Leukocyte Antigen Antibodies
Arnaud Del Bello, Martine Neau‐Cransac, Laurence Lavayssiere, Valérie Dubois, Nicolas Congy‐Jolivet, Jonathan Visentin, Marie Danjoux, Brigitte Le Bail, Valérie Hervieu, Olivier Boillot, Teresa Antonini, Nassim Kamar, Jérôme Dumortier – 14 October 2019 – After liver transplantation (LT), the role of preformed donor‐specific anti–human leukocyte antigen antibodies (pDSAs) remains incompletely understood. We conducted a retrospective, case‐control analysis to determine the impact of pDSAs after LT in 3 French transplant centers (Bordeaux, Lyon, and Toulouse).
Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain–Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma
Carmen Oi Ning Leung, Man Tong, Katherine Po Sin Chung, Lena Zhou, Noélia Che, Kwan Ho Tang, Jin Ding, Eunice Yuen Ting Lau, Irene Oi Lin Ng, Stephanie Ma, Terence Kin Wah Lee – 14 October 2019
Tuberculosis Treatment With a 3‐Drug Rifamycin‐Free Regimen in Liver Transplant Recipients
Timothy Sullivan, Samantha Jacobs, Jennifer Leong, Dallas Dunn, Emily Baneman, Sarah Taimur, Shirish Huprikar, Meenakshi Rana – 13 October 2019
Everolimus: Longer‐Term CERTITUDE
Omar Y. Mousa, Andrew P. Keaveny – 13 October 2019
Changing Etiologies and Prognostic Factors in Pediatric Acute Liver Failure
Manuel Mendizabal, Marcelo Dip, Ezequiel Demirdjian, Leandro Lauferman, Susana Lopez, Julia Minetto, Alejandro Costaguta, Carolina Rumbo, Ivone Malla, María Camila Sanchez, Esteban Halac, Guillermo Cervio, Miriam Cuarterolo, Marcela Galoppo, Oscar Imventarza, Liliana Bisgniano, Daniel D’Agostino, Fernando Rubinstein – 13 October 2019 – After the implementation of universal hepatitis A virus vaccination in Argentina, the outcome of pediatric acute liver failure (PALF) remains unknown.
Novel Arterial Reconstruction With Donor Femoral Artery in Split‐Liver Transplantation
Flavio Paterno, Lloyd Brown, Dorian Wilson, Nikolaos Pyrsopoulos, James V. Guarrera – 12 October 2019